Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

August 22, 2014

Regulatory, Supply Issues Haunt Ebola Drug Makers

Medical staff and supplies are urgently needed to fight the disease.

Regulatory, Supply Issues Haunt Ebola Drug Makers

National and international organizations, scientists, and companies are all on the search for new treatments and potential cures. [© luchschen_shutter - Fotolia.com]

As of August 16th, 2,240 individuals had contracted Ebola virus—a filovirus causing a hemorrhagic fever in humans and nonhuman primates so deadly that it kills over 90% of its victims—in Guinea, Liberia, Sierra Leone, and Nigeria, resulting in 1,229 deaths The international community, recognizing the urgency of the outbreak, has ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content